Reduced expression of systemic proinflammatory and myocardial biomarkers after off-pump versus on-pump coronary artery bypass surgery: A prospective randomized study
Carlos Serrano(Universidade de São Paulo), Whady Hueb(Universidade de São Paulo), Juliano Lara Fernandes(Universidade Estadual de Campinas (UNICAMP)), Juliana Almeida‐de‐Souza(Universidade de São Paulo), José Antônio Franchini Ramires(Universidade de São Paulo), José Carlos Nicolau(Hospital São Paulo), Neuza Lopes(Universidade de São Paulo), Maria Heloı́sa Souza Lima Blotta(Universidade Estadual de Campinas (UNICAMP))
Cited by 56
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
|New England Journal of Medicine|2015|2k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Transfusion Requirements After Cardiac Surgery
|JAMA|2010|1k